Tchaikapharma High Quality Medicines AD (BUL:THQM)
17.60
0.00 (0.00%)
At close: May 8, 2025
BUL:THQM Revenue
Tchaikapharma High Quality Medicines AD had revenue of 16.19M BGN in the quarter ending March 31, 2025, with 21.16% growth. This brings the company's revenue in the last twelve months to 55.97M, up 15.96% year-over-year. In the year 2024, Tchaikapharma High Quality Medicines AD had annual revenue of 53.14M with 9.54% growth.
Revenue (ttm)
55.97M
Revenue Growth
+15.96%
P/S Ratio
28.87
Revenue / Employee
518.22K
Employees
207
Market Cap
1.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 53.14M | 4.63M | 9.54% |
Dec 31, 2023 | 48.51M | 5.37M | 12.44% |
Dec 31, 2022 | 43.15M | 715.00K | 1.69% |
Dec 31, 2021 | 42.43M | 2.33M | 5.80% |
Dec 31, 2020 | 40.11M | 5.38M | 15.50% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shelly Group SE | 208.70M |
Speedy AD | 519.17M |
Sopharma AD | 2.14B |
First Investment Bank AD | 418.43M |
Eurohold Bulgaria AD | 2.79B |
M+S Hydraulic AD | 144.82M |
Smart Organic AD | 93.58M |
Holding Varna AD | 86.75M |